[Tumor dormancy therapy for hepatocellular carcinoma]

Nihon Rinsho. 2001 Oct:59 Suppl 6:824-8.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Angiostatins
  • Antibodies / therapeutic use
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Hepatocellular / blood supply
  • Carcinoma, Hepatocellular / therapy*
  • Collagen / therapeutic use
  • Endostatins
  • Endothelial Growth Factors / immunology
  • Hepatocyte Growth Factor / antagonists & inhibitors
  • Hepatocyte Growth Factor / pharmacology
  • Hepatocyte Growth Factor / therapeutic use
  • Humans
  • Hydroxamic Acids / therapeutic use
  • Liver Neoplasms / blood supply
  • Liver Neoplasms / therapy*
  • Lymphokines / immunology
  • Matrix Metalloproteinase Inhibitors
  • Mitogens*
  • Peptide Fragments / therapeutic use
  • Plasminogen / therapeutic use
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Antibodies
  • Antineoplastic Agents
  • Endostatins
  • Endothelial Growth Factors
  • HGF protein, human
  • Hydroxamic Acids
  • Lymphokines
  • Matrix Metalloproteinase Inhibitors
  • Mitogens
  • Peptide Fragments
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Hepatocyte Growth Factor
  • Angiostatins
  • Plasminogen
  • Collagen
  • marimastat